TMC Life Sciences (0101.KU) - Malaysia
(1st) quarter ended Sep 30:
Figures Are In Ringgit (MYR).
2025 2024
Revenue 100,477,000 81,967,000
PreTax Profit 6,567,000 4,459,000
Net Profit 4,413,000 2,936,000
Earnings Per Share 0.25 Sen 0.17 Sen
Dividend 0.00 Sen 0.00 Sen
(END) Dow Jones Newswires
November 21, 2025 05:36 ET (10:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.